Skip to main content

Table 1 Brain samples demographics. For age at death and post-mortem delay data are presented as mean and (standard deviation)

From: Tau protein profiling in tauopathies: a human brain study

  

Brain region

Female (%)

Age at death (years)

Post-mortem delay, (hours)

Braak stages 0/I-II/III-IV/V-VI

Thal phases 0/1–2/3/4–5

CAA 0/1/2/3

Cohort 1

Control (n = 10)

FGM

6 (60%)

78.7 (17.7)

77.6 (42.8)

3/7/0/0

4/4/1/1

8/2/0/0

AD (n = 10)

FGM

4 (40%)

69.4 (8.1)

53.8 (28.9)

0/0/0/10

0/0/0/10

1/1/1/7

PSP (n = 11)

FGM

5 (45%)

79.3 (9.0)

47.9 (21.6)

na

na

na

CBD (n = 10)

FGM

3 (30%)

68.6 (4.9)

73.0 (25.1)

na

na

na

PiD (n = 10)

FGM

1 (10%)

69.8 (4.8)

67.4 (27.3)

na

na

na

Cohort 2

Control (n = 10)

FGM

2 (20%)

78.0 (7.0)

56.0 (30.6)

2/4/4/0

2/3/4/1

6/1/1/2

AD (n = 10)

FGM

6 (60%)

75.8 (6.7)

58.6 (23.1)

0/0/0/10

0/0/0/10

0/2/2/6

CBD (n = 10)

FGM

6 (60%)

71.0 (7.2)

78.0 (28.9)

3/4/2/0

4/2/0/5

6/2/1/0

  1. FGM = frontal grey matter, CAA = cerebral amyloid angiopathy, AD = (sporadic) Alzheimer’s diseases, PSP = progressive sopranuclear palsy, CBD = corticobasal neurodegeneration, PiD = Pick’s disease, na = not analyzed